The number of specimens with positive EZH2 staining gradually increased from 12.5% (5/40) in the normal cervical tissues to 43.9% (18/41) in the cervical cancer in situ tissues, and then to 74.2% (46/62) in the cervical cancer tissues (Supplementary Table 1 and Figure 1B). The gene discussed is EZH2; the disease is cervical carcinoma.